Five-Year Outcomes after Randomized Treatment by Rituximab in Early Acute Antibody-Mediated Rejection in Renal Transplantation: Long Term Outcomes of the RITUX ERAH Study.

Affiliation auteurs!!!! Error affiliation !!!!
TitreFive-Year Outcomes after Randomized Treatment by Rituximab in Early Acute Antibody-Mediated Rejection in Renal Transplantation: Long Term Outcomes of the RITUX ERAH Study.
Type de publicationJournal Article
Year of Publication2018
AuteursBailly E., Blancho G., Ville S., Morelon E., Bamoulid J., Caillard S., Chatelet V., Malvezzi P., Tourret J., Vuiblet V., Anglicheau D., Bertrand D., Grimbert P., Haidar F., Hazzan M., Kamar N., Merville P., Mousson C., Pernin V., Pouteil-Noble C., Purgus R., Sayegh J., Westeel P., Buchler M.
JournalAMERICAN JOURNAL OF TRANSPLANTATION
Volume18
Pagination253
Date PublishedJUN
Type of ArticleMeeting Abstract
ISSN1600-6135